(Q72516643)
Statements
Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer (English)
B Chevallier
P Fumoleau
P Kerbrat
V Dieras
H Roche
I Krakowski
N Azli
M Bayssas
M A Lentz
M Van Glabbeke
1 February 1995